Completed PHASE2 INTERVENTIONAL NCT00005824

Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory AIDS-Related Lymphoma

Pilot Study of the Safety and Feasibility of Autologous Peripheral Blood Stem Cell Transplantation for Patients With Relapsed AIDS-Related Lymphoma

Sponsor: AIDS Malignancy Consortium

Conditions Lymphoma

Interventions busulfan cyclophosphamide filgrastim peripheral blood stem cell transplantation

Updated 5 times since 2017 Last updated: Feb 1, 2016 Started: Nov 30, 2000 Primary completion: Jul 31, 2004 Completion: Apr 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Lymphoma, this trial is completed. The trial is conducted by AIDS Malignancy Consortium and has accumulated 5 data snapshots since 2000. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Nov 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AIDS Malignancy Consortium
National Cancer Institute (NCI)

Data source: AIDS Malignancy Consortium

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States
• Boston, United States